Barclays’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-144
| Closed | -$1K | – | 4019 |
|
|
2019
Q4 | $1K | Sell |
144
-9,856
| -99% | -$68.4K | ﹤0.01% | 3823 |
|
|
2019
Q3 | $65K | Buy |
+10,000
| New | +$65K | ﹤0.01% | 3598 |
|
|
2019
Q2 | – | Sell |
-238
| Closed | -$3K | – | 4521 |
|
|
2019
Q1 | $3K | Buy |
238
+188
| +376% | +$2.37K | ﹤0.01% | 4138 |
|
|
2018
Q4 | $0 | Buy |
50
+32
| +178% | – | ﹤0.01% | 4504 |
|
|
2018
Q3 | $0 | Sell |
18
-18,327
| -100% | – | ﹤0.01% | 4545 |
|
|
2018
Q2 | $332K | Buy |
18,345
+9,692
| +112% | +$175K | ﹤0.01% | 2497 |
|
|
2018
Q1 | $91K | Sell |
8,653
-10,464
| -55% | -$110K | ﹤0.01% | 3206 |
|
|
2017
Q4 | $806K | Buy |
19,117
+17,789
| +1,340% | +$750K | ﹤0.01% | 1768 |
|
|
2017
Q3 | $73K | Sell |
1,328
-9,131
| -87% | -$502K | ﹤0.01% | 2826 |
|
|
2017
Q2 | $1.94M | Buy |
10,459
+10,204
| +4,002% | +$1.89M | ﹤0.01% | 1225 |
|
|
2017
Q1 | $31K | Sell |
255
-437
| -63% | -$53.1K | ﹤0.01% | 3253 |
|
|
2016
Q4 | $68K | Buy |
692
+612
| +765% | +$60.1K | ﹤0.01% | 2730 |
|
|
2016
Q3 | $9K | Buy |
+80
| New | +$9K | ﹤0.01% | 3298 |
|